IDG leads $80m Series B round in Chinese biotech firm PTM Biolabs

IDG leads $80m Series B round in Chinese biotech firm PTM Biolabs

Laboratory equipment. Photo: Pixabay

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter